Canine Biologics

Canine Biologics

Dogs and humans enjoy the most amazing cross-species relationship in the history of the planet! We want to honor that when they need our help the most. Given all they do for us and the lack specific nutrition for dogs in the fight of their lives, we wanted to help them enjoy their highest quality of life.

View on Wefunder
Security Type
Min Investment
Denver, CO
Min Raise
Offering Date
May 05, 2021
Max Raise
Expected Close Date
April 30, 2022


Jeff Sutherland, Founder, President & CEO
Founder of two pet food companies. Broad, international career with extensive experience in marketing, IT and management consulting. Significant Industry-specific experience in biotechnology, healthcare and finance.

Afshin Safavi, Chairman & Chief Science Officer
Dr. Afshin Safavi is a founder, consultant, board member, entrepreneur, and investor in biotech, Animal Health, pharma, IT, and real-estate. He holds a B.S. (Biochemistry) from UCLA, and a Ph.D. (Biochemistry) from Univ. of Kentucky Medical School.

Charles Mueller,
Mr. Mueller is a former CFO for three companies specializing in manufacturing, software and the oil and gas industry, each with sales in excess of $200 million per annum.

Research Reports

No reports have been submitted

Become a Reporter

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.

Key Deal Facts

6 consecutive months of positive revenue growth since entering the market. (Nov - April MTD)
Market Potential: 500,000 dogs (US and Canada) diagnosed with cancer each month
Experienced team includes PhD veterinarians with advanced expertise in nutrition and cancer care
We believe there are no other companies offering complete products (food + supplements) for dogs with cancer
Expanded product roadmap includes formulated treats, liquid diet for dogs requiring tube feeding